Hassanpour SH, Dehghani M. Review of cancer from perspective of molecular. J Cancer Res Pract. 2017;4(4):127–9.

Article  Google Scholar 

Saini A, Kumar M, Bhatt S, Saini V, Malik A. Cancer causes and treatments. Int J Pharm Sci Res. 2020;11(7):3121–34.

CAS  Google Scholar 

Sood A, Mehrotra A, Sharma U, Aggarwal D, Singh T, Shahwan M, Jairoun AA, Rani I, Ramniwas S, Tuli HS, Yadav V, Kumar M. Advancements and recent explorations of anti-cancer activity of chrysin: from molecular targets to therapeutic perspective. Explor Target Antitumor Ther. 2024;5(3):477–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu H, Luo Z, Luo F, Wang X, Wei H, Yu C-Y. Intratumoral microbiota: a new perspective in cancer initiation, development, and therapy. RSC Pharm. 2025;2:865–81.

Article  CAS  Google Scholar 

Thongsom S, Di Gianvincenzo P, Ciattaglia G, Subrati A, DiSilvio D, Birocco AM, D’Abramo M, Boonla C, Chanvorachote P, Moya SE. Cyclodextrin-based nanosponge co-delivery of doxorubicin and EMD: synergistic anticancer activity with improved selectivity toward cancer cells. RSC Pharm. 2025;2:1514–32.

Article  CAS  Google Scholar 

Bercu JP, Morinello EJ, Sehner C, Shipp BK, Weideman PA. Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs). Regul Toxicol Pharmacol. 2016;79(Suppl 1):S48–56.

Article  CAS  PubMed  Google Scholar 

Parchen GP, Quaillet M, de Freitas RA, Hillaireau H. Chitosan-based nano-objects for drug delivery: a review of their chemical modifications, supramolecular organization and biological fate. RSC Pharm. 2025;2:1292–322.

Article  Google Scholar 

Vugmeyster Y, Xu X, Theil F-P, Khawli LA, Leach MW. Pharmacokinetics and toxicology of therapeutic proteins: advances and challenges. World J Biol Chem. 2012;3(4):73–92.

Article  PubMed  PubMed Central  Google Scholar 

Teasdale A, Elder D, Harvey J, Spanhaak S. Impurities in new drug substances and new drug products. In: Teasdale A, Elder D, Nims RW, editors. ICH quality guidelines: an implementation guide. Hoboken: Wiley; 2017. pp. 167–198.

Cordeiro CF, Franco LL, Carvalho DT, Bonfilio R. Impurities in active pharmaceutical ingredients and drug products: a critical review. Crit Rev Anal Chem. 2024;56(1):55–75.

Panchal A, Musyuni P, Aggarwal G. Regulatory perspective of cancer drug development: an overview. J Generic Med. 2023;19(4):179–85.

Article  Google Scholar 

Michaeli DT, Mills M, Michaeli T, Miracolo A, Kanavos P. Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA. Investig New Drugs. 2022;40:798–809.

Article  Google Scholar 

Minami H, Kiyota N, Kimbara S, Ando Y, Shimokata T, Ohtsu A, Fuse N, Kuboki Y, Shimizu T, Yamamoto N, Nishio K, Kawakami Y, Nihira S, Sase K, Nonaka T, Takahashi H, Komori Y, Kiyohara K. Guidelines for clinical evaluation of anti-cancer drugs. Cancer Sci. 2021;112(7):2563–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akash MSH, Rehman K. Essentials of pharmaceutical analysis. Essentials of pharmaceutical analysis. Singapore: Springer; 2025. pp. 1–25.

Chapter  Google Scholar 

Akash MSH, Rehman K. Comprehensive insights into gas chromatography. Essentials of pharmaceutical analysis. Singapore: Springer; 2025. pp. 757–796.

Liao GQ, Tang HM, Yu YD, Fu LZ, Li S-J, Zhu MX. Mass spectrometry-based metabolomics as a powerful tool to unravel the component and mechanism in TCM. Chin Med. 2025;20:62.

Article  PubMed  PubMed Central  Google Scholar 

Singhal A, Saini U, Chopra B, Dhingra AK, Jain A, Chaudhary J. UV-visible spectroscopy: a review on its pharmaceutical and bio-allied sciences applications. Curr Pharm Anal. 2024;20(3):161–77.

Article  CAS  Google Scholar 

Pagade S, Agrawal S, Shejal P, Chougule P, Chougule N. Detection of impurities: a review on advances in impurities detection and characterization in pharmaceuticals by analytical techniques. Int J Pharm Sci. 2023;1(12):860–79.

Google Scholar 

Gangadharan AS, Venu VMA, Thangadurai TD, Lee YI. Exploring spectroscopy’s impact in pharmaceutical and biomedical sciences: an insightful review. Appl Spectrosc Rev. 2025;60(9–10):919–56.

Article  Google Scholar 

Kirkland D, Snodin D. Setting limits for genotoxic impurities in drug substances: threshold-based and pragmatic approaches. Int J Pharm Med. 2004;18:197–207.

Article  Google Scholar 

Barge V, Phuge AN. Analytical perspectives on chromatographic method development for impurity profiling in pharmaceuticals. J Pharm Sci 2025;1(11):Article ID JPS/0110151.

Tuzimski T, Petruczynik A. Review of chromatographic methods coupled with modern detection techniques applied in therapeutic drugs monitoring (TDM). Molecules. 2020;25(17):4026.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gorog S. Critical review of reports on impurity and degradation product profiling in the last decade. Trends Anal Chem. 2018;101:2–16.

Article  CAS  Google Scholar 

Sobolewska E, Biesaga M. High-performance liquid chromatography methods for determining the purity of drugs with weak UV chromophores—a review. Crit Rev Anal Chem. 2025;55(3):419–33.

Article  CAS  PubMed  Google Scholar 

Sharma S, Singh N, Ankalgi AD, Rana A, Ashawat MS. Modern trends in analytical techniques for method development and validation of pharmaceuticals: a review. J Drug Deliv Ther. 2021;11:121.

Article  CAS  Google Scholar 

Bunaciu AA, Aboul-Enein HY, Fleschin S. Application of Fourier transform infrared spectrophotometry in pharmaceutical drugs analysis. Appl Spectrosc Rev. 2010;45(3):206–19.

Article  Google Scholar 

Branch SK. Guidelines from the international conference on harmonisation (ICH). J Pharm Biomed Anal. 2005;38(5):798–805.

Article  CAS  PubMed  Google Scholar 

Holzgrabe U, Wawer I, Diehl B. NMR spectroscopy in drug development and analysis. Weinheim, Germany: Wiley-VCH; 1999. pp. 16–60.

Book  Google Scholar 

Holzgrabe U. Quantitative NMR spectroscopy in pharmaceutical applications. Prog Nucl Magn Reson Spectrosc. 2010;57(2):229–40.

Article  CAS  PubMed  Google Scholar 

Emwas A-H, Szczepski K, Poulson BG, Chandra K, McKay RT, Dhahri M, Alahmari F, Jaremko L, Lachowicz JI, Jaremko M. NMR as a gold standard method in drug design and discovery. Molecules. 2020;25(20):4597.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohammed A-FA, Li B, Hong J, Xu W, Zhai Y. Rapid detection of surface chemical residues by miniature mass spectrometry. Talanta 2026;297(Part B):128707.

Khalikova M, Jires J, Horacek O, Dousa M, Kucera R, Novakova L. What is the role of current mass spectrometry in pharmaceutical analysis? Mass Spectrom Rev. 2023;43(3):560–609.

Yuabova ZY, Holschlag DR, Rodriguez SA, Qin C, Papov VV, Qiu F. Genotoxic impurities: a quantitative approach. J Liq Chromatogr Relat Technol. 2008;31(15):2318–30.

Article  CAS  Google Scholar 

Ferenczi-Fodor K, Vegh Z, Renger B. Thin-layer chromatography in testing the purity of pharmaceuticals. Trends Anal Chem. 2006;25(8):778–89.

Article  CAS  Google Scholar 

Gorog S. Identification in drug quality control and drug research. Trends Anal Chem. 2015;69:114–22.

Article  CAS  Google Scholar 

Abdelaleem EA, Abdelwahab NS. Stability-indicating TLC–densitometric method for simultaneous determination of paracetamol and chlorzoxazone and their toxic impurities. J Chromatogr Sci. 2013;51(2):187–91.

Article  CAS  PubMed  Google Scholar 

Jyothesh Kumar GT, Andrews BSA, Abbaraju VDNK. Method development in pharmaceutical chemistry analysis by chromatography: a comprehensive review. Anal Methods Environ Chem J. 2025;8(3):147–81.

Article  Google Scholar 

Saraswat S, Snyder B, Isailovic D. Quantification of HPLC-separated peptides and proteins by spectrofluorimetric detection of native fluorescence and mass spectrometry. J Chromatogr B. 2012;902:70–7.

Article  CAS  Google Scholar 

Tettey JNA, Skellern GG, Midgley JM, Grant MH. HPTLC and HPLC determination of isometamidium in the presence of its manufacturing and degradation impurities. J Pharm Biomed Anal. 1998;17(4–5):713–8.

Article  CAS  PubMed  Google Scholar 

Hussien EM. HPLC method validation for modernization of the tetracycline hydrochloride capsule USP monograph. Bull Fac Pharm Cairo Univ. 2014;52(2):239–44.

Google Scholar 

Li S, Wang W, Tang H, Chen K, Yang J, He L, Ye H, Peng A, Chen L. Comparison of counter-current chromatography and preparative high performance liquid chromatography applied to separating minor impurities in drug preparations. J Chromatogr A. 2014;1347:51–8.

Article  Google Scholar